[Federal Register Volume 71, Number 106 (Friday, June 2, 2006)]
[Notices]
[Pages 32110-32111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-5059]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


First-Generation Guidelines for NCI-Supported Biorepositories

AGENCY: National Institutes of Health (NIH), National Cancer Institute 
(NCI), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The public comment period for the First Generation Guidelines 
for NCI-Supported Biorepositories (Federal Register, Vol. 71, Number 
82, Page 25814, April 28, 2006) will be extended an additional 30 days 
beyond publication of this notice.

DATES: Effective Date: July 3, 2006.

FOR FURTHER INFORMATION CONTACT: Implementation assistance and 
inquiries should be directed to senior staff of the

[[Page 32111]]

relevant NCI Extramural and Intramural Program offices.

ADDRESSES: Written comments should be sent to: First-Generation 
Guidelines, Office of Biorepositories and Biospecimen Research, Office 
of the Deputy Director for Advanced Technologies and Strategic 
Partnerships, National Cancer Institute, National Institutes of Health, 
31 Center Drive, Room 10A03, Bethesda, MD 20892. Comments submitted via 
e-mail should use [email protected] and enter ``First-Generation 
Guidelines Comment'' in the subject line.

SUPPLEMENTARY INFORMATION: In order to have adequate time to review and 
comment on these Guidelines, several individuals and organizations have 
requested an extension of the 30-day public comment period, scheduled 
to end May 30, 2006. The NCI agrees that, due to the amount of time 
that it will take for many organizations to review the Guidelines and 
draft through responses, an extension of the 30-day comment period is 
warranted. Therefore the public comment period will be extended an 
additional 30 days beyond the publication date of this notice. After 
the comment period has closed, any comments received will be considered 
in a timely manner by the NCI Office of Biorepositories and Biospecimen 
Research and appropriate changes will be made and the final guidelines 
will be published and voluntarily in effect. After the effective date 
of publication of the final guidelines, written comments will continue 
to be accepted for the first year of implementation and can be sent to: 
First-Generation Guidelines, Office of Biorepositories and Biospecimen 
Research, Office of the Deputy Director for Advanced Technologies and 
Strategic Partnerships, National Cancer Institute, National Institutes 
of Health, 31 Center Drive, Room 10A03, Bethesda, MD 20892. Comments 
submitted via e-mail should use [email protected] and enter 
``First-Generation Guidelines Comment'' in the subject line. During the 
first year of implementation, the NCI will review any additional 
comments and experience with the guidelines to evaluate a possible need 
for future guidelines modification.

    Dated: May 25, 2006.
John Niederhuber,
Deputy Director, National Center Institute, Deputy Director for 
Translational & Clinical Sciences.
[FR Doc. 06-5059 Filed 6-1-06; 8:45 am]
BILLING CODE 4140-01-M